Growth Metrics

Evolent Health (EVH) FCF Margin (2016 - 2026)

Evolent Health has reported FCF Margin over the past 11 years, most recently at 8.76% for Q4 2025.

  • For Q4 2025, FCF Margin rose 1376.0% year-over-year to 8.76%; the TTM value through Dec 2025 reached 0.25%, up 49.0%, while the annual FY2025 figure was 0.25%, 49.0% up from the prior year.
  • FCF Margin for Q4 2025 was 8.76% at Evolent Health, up from 1.43% in the prior quarter.
  • Over five years, FCF Margin peaked at 23.92% in Q4 2021 and troughed at 25.16% in Q1 2021.
  • A 5-year average of 0.22% and a median of 0.66% in 2022 define the central range for FCF Margin.
  • On a YoY basis, FCF Margin climbed as much as 3151bps in 2021 and fell as far as -2613bps in 2021.
  • Year by year, FCF Margin stood at 23.92% in 2021, then crashed by -73bps to 6.52% in 2022, then soared by 130bps to 14.99% in 2023, then crashed by -133bps to 5.01% in 2024, then surged by 275bps to 8.76% in 2025.
  • Business Quant data shows FCF Margin for EVH at 8.76% in Q4 2025, 1.43% in Q3 2025, and 8.8% in Q2 2025.